For-profit organizations · Calgary, Alberta
Fluid Biotech Inc.
- Total value
- $611K
- Agreements
- 6
- Programs
- 4
- First and latest
- 2019–2021
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Regional Economic Growth through Innovation | Western Economic Diversification Canada | 1 | $350K |
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 2 | $150K |
| Industrial Research Assistance Program – Innovation Assistance Program | National Research Council Canada | 2 | $70K |
| Innovation Assistance Program | National Research Council Canada | 1 | $41K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Jan 2021 | Regional Economic Growth through InnovationWestern Economic Diversification Canada | Contribution | $350,000 |
| Dec 2020 | Industrial Research Assistance Program – Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance Program – Round 2.5Contribution | $21,676 |
| Aug 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Determining In Vitro and In Vivo Absorption and Flow Diversion Characteristics of a Novel Bioabsorbable Stent for Aneurysms.Contribution | $100,000 |
| Jun 2020 | Industrial Research Assistance Program – Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance Program – Round 2Contribution | $48,704 |
| Apr 2020 | Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance ProgramContribution | $40,656 |
| Oct 2019 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Phase 1: Determining the In Vivo Safety and Efficacy Characteristics of a Bioabsorbable Flow-Diverting StentContribution | $50,000 |